{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:26Z","timestamp":1794330266435,"version":"4.9.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["SBGJ202301010"],"award-info":[{"award-number":["SBGJ202301010"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Research and Development Plan Major Project Jointly Constructed by the Henan Province and Ministerial Departments in China"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105791","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:30:55Z","timestamp":1749220255000},"page":"105791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8484-6603","authenticated-orcid":false,"given":"Wanqing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-7989","authenticated-orcid":false,"given":"Hongwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105791_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ebiom.2025.105791_bib2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2337\/dc20-2232","article-title":"Not only diabetes but also prediabetes leads to functional decline and disability in older adults","volume":"44","author":"Shang","year":"2021","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2025.105791_bib3","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0140-6736(23)02078-0","article-title":"Tracing the temporal trends of modifiable risk factors in dementia: insights from the English Longitudinal Study of Ageing (2004\u20132019)","volume":"402","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105791_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","article-title":"Diabetes mellitus and dementia","volume":"14","author":"Ninomiya","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ebiom.2025.105791_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104642","article-title":"Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies","volume":"137","author":"Luo","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ebiom.2025.105791_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cmet.2022.08.004","article-title":"Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.105791_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ebiom.2025.105791_bib8","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00125-020-05264-8","article-title":"Higher BMI is associated with smaller regional brain volume in older adults with type 2 diabetes","volume":"63","author":"West","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2025.105791_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ebiom.2025.105791_bib10","article-title":"Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes","volume":"6","author":"Liu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2025.105791_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2025.105791_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2025.105791_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12967-024-04927-z","article-title":"Tirzepatide prevents neurodegeneration through multiple molecular pathways","volume":"22","author":"Fontanella","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.ebiom.2025.105791_bib14","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.7150\/thno.86831","article-title":"Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists","volume":"13","author":"Ghosh","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ebiom.2025.105791_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/alz.12474","article-title":"Brain energy failure in dementia syndromes: opportunities and challenges for glucagon-like peptide-1 receptor agonists","volume":"18","author":"Yassine","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2025.105791_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmet.2013.12.001","article-title":"Action and therapeutic potential of oxyntomodulin","volume":"3","author":"Pocai","year":"2014","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib17","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1038\/s41467-023-44067-4","article-title":"A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity","volume":"14","author":"Ji","year":"2023","journal-title":"Nat Commun"},{"issue":"Supplement_ 1","key":"10.1016\/j.ebiom.2025.105791_bib18","article-title":"1856-LB: efficacy and safety of mazdutide in Chinese participants with overweight or obesity (GLORY-1)","volume":"73","author":"Ji","year":"2024","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105791_bib19","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1080\/15548627.2021.1886720","article-title":"Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB)","volume":"17","author":"Zheng","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ebiom.2025.105791_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116754","article-title":"Neuroprotective effects of Anshen Bunao Syrup on cognitive dysfunction in Alzheimer's disease rat models","volume":"176","author":"Sun","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2025.105791_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109970","article-title":"Knockdown of CLC-3 may improve cognitive impairment caused by diabetic encephalopathy","volume":"190","author":"Jingxuan","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41401-020-0407-5","article-title":"Drinking water temperature affects cognitive function and progression of Alzheimer's disease in a mouse model","volume":"42","author":"Wei","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ebiom.2025.105791_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbi.2024.03.031","article-title":"Multi-strain probiotics ameliorate Alzheimer's-like cognitive impairment and pathological changes through the AKT\/GSK-3\u03b2 pathway in senescence-accelerated mouse prone 8 mice","volume":"119","author":"Xiao-Hang","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ebiom.2025.105791_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154930","article-title":"Eugenol relieves the pathological manifestations of Alzheimer's disease in 5\u00d7FAD mice","volume":"118","author":"Jung","year":"2023","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105791_bib25","doi-asserted-by":"crossref","DOI":"10.1289\/EHP10255","article-title":"Evaluation of neurotoxicity in BALB\/c mice following chronic exposure to polystyrene microplastics","volume":"130","author":"Jin","year":"2022","journal-title":"Environ Health Perspect"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13020-021-00425-2","article-title":"Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the A\u03b2 deposition and JAK2\/STAT3 signaling pathway in AD model of APP\/PS1 transgenic mice","volume":"16","author":"Long","year":"2021","journal-title":"Chin Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12906-019-2738-7","article-title":"Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Complement Med Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105791_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.105791_bib29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41593-018-0121-5","article-title":"Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex","volume":"21","author":"Hughes","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2025.105791_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.1254960","article-title":"Motor skill learning requires active central myelination","volume":"346","author":"McKenzie","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105791_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nn.3045","article-title":"Plasticity in gray and white: neuroimaging changes in brain structure during learning","volume":"15","author":"Zatorre","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ebiom.2025.105791_bib32","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.cell.2018.10.044","article-title":"Spatiotemporal control of CNS myelination by oligodendrocyte programmed cell death through the TFEB-PUMA axis","volume":"175","author":"Sun","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2025.105791_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer's disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105791_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102095","article-title":"Associations of olfactory function with brain structural and functional outcomes. A systematic review","volume":"92","author":"Bothwell","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ebiom.2025.105791_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104707","article-title":"Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer's disease","volume":"135","author":"Akhtar","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/j.ebiom.2025.105791_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ebiom.2025.105791_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114105","article-title":"Protective effects of CCL01 against A\u03b2-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease","volume":"158","author":"Ju","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2025.105791_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molmed.2023.09.005","article-title":"Diabetes: a tipping point in neurodegenerative diseases","volume":"29","author":"Santiago","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2025.105791_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ebiom.2025.105791_bib40","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2025.105791_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","article-title":"Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions","volume":"9","author":"Jalleh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2025.105791_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105791_bib43","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1002\/alz.13882","article-title":"Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis","volume":"20","author":"Ding","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2025.105791_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-07696-3","article-title":"Author Correction: microglia regulate central nervous system myelin growth and integrity","volume":"631","author":"McNamara","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105791_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.689678","article-title":"Proglucagon-derived peptides as therapeutics","volume":"12","author":"Lafferty","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ebiom.2025.105791_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","article-title":"Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease","volume":"28","author":"Nowell","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2025.105791_bib47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JIM.0000000000000129","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes","volume":"63","author":"Xu","year":"2015","journal-title":"J Investig Med"},{"key":"10.1016\/j.ebiom.2025.105791_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","article-title":"Energy metabolism and inflammation in brain aging and Alzheimer's disease","volume":"100","author":"Yin","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ebiom.2025.105791_bib49","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(18)30726-8","article-title":"MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study","volume":"391","author":"Ambery","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105791_bib50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12020-024-04013-w","article-title":"Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis","volume":"87","author":"Ma","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.ebiom.2025.105791_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.ebiom.2025.105791_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101242","article-title":"Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R\/GCGR co-agonist","volume":"51","author":"Pickford","year":"2021","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105791_bib53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/156720509788929282","article-title":"Treatment of mild cognitive impairment (MCI)","volume":"6","author":"Farlow","year":"2009","journal-title":"Curr Alzheimer Res"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105791_bib54","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/11201020-000000000-00000","article-title":"Memantine: a review of its use in moderate to severe Alzheimer's disease","volume":"23","author":"McKeage","year":"2009","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ebiom.2025.105791_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113113","article-title":"Neurotrophic and neuroprotective effects of a monomeric GLP-1\/GIP\/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury","volume":"324","author":"Li","year":"2020","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2009.09.032","article-title":"New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)","volume":"22","author":"Yu","year":"2010","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105791_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12929-024-01061-2","article-title":"CPEB2-activated axonal translation of VGLUT2 mRNA promotes glutamatergic transmission and presynaptic plasticity","volume":"31","author":"Lu","year":"2024","journal-title":"J Biomed Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105791_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108094","article-title":"Distinct signaling by ventral tegmental area glutamate, GABA, and combinatorial glutamate-GABA neurons in motivated behavior","volume":"32","author":"Root","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105791_bib61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nn.3935","article-title":"A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity","volume":"18","author":"Verma","year":"2015","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2011.08.027","article-title":"Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex","volume":"45","author":"Sokolow","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"52","key":"10.1016\/j.ebiom.2025.105791_bib63","doi-asserted-by":"crossref","first-page":"14326","DOI":"10.1523\/JNEUROSCI.4433-07.2007","article-title":"NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABA(A) receptors","volume":"27","author":"Marsden","year":"2007","journal-title":"J Neurosci"},{"issue":"38","key":"10.1016\/j.ebiom.2025.105791_bib64","doi-asserted-by":"crossref","first-page":"16679","DOI":"10.1073\/pnas.1000589107","article-title":"NMDA receptors regulate GABAA receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the \u03b32 subunit","volume":"107","author":"Muir","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7952","key":"10.1016\/j.ebiom.2025.105791_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","article-title":"Macrophage fumarate hydratase restrains mtRNA-mediated interferon production","volume":"615","author":"Hooftman","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105791_bib66","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/aje\/kwz116","article-title":"Association between serum \u03b2-alanine and risk of dementia","volume":"188","author":"Hata","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105791_bib67","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3233\/JAD-215725","article-title":"Cerebrospinal fluid amino acid metabolite signatures of diabetic cognitive dysfunction based on targeted mass spectrometry","volume":"86","author":"Zhao","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1039\/c5tx00171d","article-title":"Screening and validation for plasma biomarkers of nephrotoxicity based on metabolomics in male rats","volume":"5","author":"Li","year":"2016","journal-title":"Toxicol Res (Camb)"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105791_bib69","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ncpendmet0318","article-title":"The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control","volume":"2","author":"Wynne","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2025.105791_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01112","article-title":"Glucagon-like peptide-1: a focus on neurodegenerative diseases","volume":"13","author":"Grieco","year":"2019","journal-title":"Front Neurosci"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105791_bib71","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2174\/138161206776873671","article-title":"Glucagon and glucagon-like peptide receptors as drug targets","volume":"12","author":"Estall","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105791_bib72","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105791_bib73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.21037\/atm.2017.11.10","article-title":"Semaglutide seems to be more effective the other GLP-1Ras","volume":"5","author":"Holst","year":"2017","journal-title":"Ann Transl Med"},{"issue":"18","key":"10.1016\/j.ebiom.2025.105791_bib74","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105791_bib75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3945\/ajcn.113.082883","article-title":"Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults","volume":"100","author":"Napoli","year":"2014","journal-title":"Am J Clin Nutr"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:16:07Z","timestamp":1752614167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":75,"alternative-id":["S235239642500235X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105791","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105791"}}